Category: Q2Syndicate content

Nobel Biocare's Q2 profits double as it fields buyout interest

August 21, 2014 by Brad Perriello

Nobel Biocare doubles its 2nd-quarter profits as it reportedly fields interest – and at least 1 offer worth $2.3 billion – from potential acquirers.

Nobel Biocare's Q2 profits double as it fields buyout interest

ConvaTec said to explore 2015 sale

August 19, 2014 by Brad Perriello

ConvaTec is reportedly weighing a sale of the private-equity-owned medical device company next year, even as interest in a Medtronic-like inversion deal mounts from C.R. Bard, CareFusion and 3M.

ConvaTec said to explore 2015 sale

Medtronic's Q1 earnings beat The Street on modest sales bump

August 19, 2014 by Brad Perriello

Medtronic's fiscal 1st-quarter earnings beat Wall Street's forecast by a penny on a modest single-digit sales increase.

Medtronic's Q1 earnings beat The Street on modest sales bump

Diabetes: DexCom's revenues jump 64% in Q2

August 11, 2014 by Arezu Sarvestani

Diabetes devices maker DexCom gets some Wall Street love after gaining major momentum in the 2nd quarter.

Diabetes: DexCom's revenues jump 64% in Q2

Diabetes devices maker  (NSDQ:DXCM) got a lot of love from Wall Street after issuing its latest quarterly report, with DXCM shares gaining 14.5% since last week.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

EnteroMedics' losses widen as it chases FDA approval

August 8, 2014 by Arezu Sarvestani

Weight-loss implant EnteroMedics falls short of analysts' expectations during its 2nd quarter as the company continues to pursue FDA approval of its flagship Maestro nerve-stimulation device.

EnteroMedics losses widen as it chases FDA approval

Minnesota-based EnteroMedics (NSDQ:ETRM) gained modestly this week after announcing its latest financial report, even though the company missed the mark by a penny.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Strong Q4, $750M buyback give CareFusion a boost

August 8, 2014 by Arezu Sarvestani

CareFusion gains a couple points after posting a Street-beating 4th quarter and announcing a $750 million share repurchase program.

Strong Q2, $750M buyback give CareFusion a boost

CareFusion (NYSE:CFN) posted a stellar 4th-quarter, posting double-digit growth in revenues and earnings and beating Wall Street's estimates.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Masimo sinks as Q2 misses the mark

August 8, 2014 by Arezu Sarvestani

Masimo's stock drops 13% as its latest quarter misses analysts' estimates and full-year guidance narrows down.

Masimo sinks as Q2 misses the mark

California device maker Masimo (NSDQ:MASI) got no Wall Street love this week after announcing results for its most recent quarter.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp